Tanvex CDMO is a leading supplier to the pharmaceutical industry, specialising in a comprehensive range of services and solutions tailored for drug development and manufacturing. The company provides expertise in various areas, including analytical and bioanalytical services, bioprocessing, formulation development, and clinical trial material production. With a commitment to quality and innovation, Tanvex CDMO supports its clients from the early stages of drug development through to commercial manufacturing, ensuring compliance with industry standards and client-specific requirements.

Services include:
- Accelerated Stability Studies
- Analytical Services
- Assay Development
- Bioanalytical Services
- Biologics
- Process Development
- Bioprocess Validation
- Bioprocessing
- Disposable/Single-Use
- Biosimilars
- Cell Culture Media Development
- Chromatography
- Clinical Trials
- Chemistry (CMC)
- Manufacturing
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Contract Research (CRO)
- Downstream Processing
- Drug Development
- Testing
- Feasibility Studies
- Fermentation
- Formulation Development
- High Throughput Screening
- Immunobiology Services
- IND/NDA Submissions
- Lot Release Testing
- Mammalian Cell Culture
- Antibody-Drug Conjugates
- Clinical Trial Materials
- Proteins
- Microbial Fermentation
- Microbiological Testing
- Parenterals Development
- Polymerase Chain Reaction
- Preclinical Testing Formulations
- Preformulation
- Process Characterization
- Process Validation Studies
- Project Management
- Protein Extraction/Purification
- Purification
- Quality QA/QC
- R&D Services
- Raw Materials Analysis
- Stability Studies
- Stability
- ICH
- Storage
- Supply Chain Management
- Technology Transfer
- UV-VIS Spectrophotometer Analysis
- Validation
- Filtration

Tanvex CDMO is dedicated to delivering exceptional service and support to its clients, ensuring that every project is handled with professionalism and expertise. For more information, please visit tanvexcdmo.com.